Network Pharmacology, Molecular Docking, and Molecular Dynamic-Based Investigation on the Mechanism of Compound Chrysanthemum in the Treatment of Asthenopia

Figure 7

Molecular docking of active compounds and hub targets. (a) The 2D and 3D structure diagrams of PRKACA and Obtusin interaction. (b) The 2D and 3D structure diagrams of PRKCA and Ethyl linolenate interaction. (c) The 2D and 3D structure diagrams of PRKCA and Glycitein interaction. (d) The 2D and 3D structure diagrams of PRKCA and Mandenol interaction. (e) The 2D and 3D structure diagrams of PRKCA and Rhein interaction. (f) The 2D and 3D structure diagrams of PRKCA and Truflex OBP interaction. (g) The 2D and 3D structure diagrams of PRKCA and Wedelolactone interaction. (h) The 2D and 3D structure diagrams of PRKCB and Atropine interaction. (i) The 2D and 3D structure diagrams of PRKCB and Glycitein interaction. (j) The 2D and 3D structure diagrams of PRKCB and Lucidusculine interaction. (k) The 2D and 3D structure diagrams of PRKCB and Rhein interaction. (l) The 2D and 3D structure diagrams of PRKCB and Wedelolactone interaction.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)